Clinicopathological indicators (age, tumor stage, nodal stage, metastasis stage) predicted poorer overall survival in those with low IL24 expression compared with those with high IL24 expression in the univariate analysis (Supplemental Table 1). Here, IL24 is linked to neoplasm.